Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-10 5:03 pm Purchase | 2026-06-03 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Glazer Capital, LLC | 2,581,700 4.850% | 2,581,700 (New Position) | Filing History |
| 2026-05-21 4:46 pm Sale | 2026-05-19 | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund, L.P. | 1,249,165 2.300% | -2,217,356 (-63.96%) | Filing History |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Point72 Asset Management, L.P. | 2,136,940 4.200% | -644,962 (-23.18%) | Filing History |
| 2026-05-13 4:40 pm Purchase | 2026-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SILVERARC CAPITAL MANAGEMENT LLC | 2,876,407 5.600% | 2,876,407 (New Position) | Filing History |
| 2026-05-01 5:32 pm Sale | 2026-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Millennium Management LLC | 1,912,146 3.700% | -1,051,553 (-35.48%) | Filing History |
| 2026-01-13 6:03 pm Purchase | 2026-01-05 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Point72 Asset Management, L.P. | 2,781,902 5.500% | 258,409 (+10.24%) | Filing History |
| 2026-01-12 6:34 pm Purchase | 2026-01-05 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Point72 Asset Management, L.P. | 2,523,493 4.900% | 2,523,493 (New Position) | Filing History |
| 2025-12-30 4:28 pm Purchase | 2025-12-23 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Millennium Management LLC | 2,963,699 5.900% | 432,689 (+17.10%) | Filing History |
| 2025-11-14 4:03 pm Sale | 2025-09-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Vestal Point Capital, LP | 750,000 1.500% | -3,250,000 (-81.25%) | Filing History |
| 2025-11-10 4:22 pm Purchase | 2025-11-04 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Millennium Management LLC | 2,531,010 5.000% | 2,531,010 (New Position) | Filing History |
| 2025-11-04 5:21 pm Purchase | 2025-11-01 | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund, L.P. | 3,466,521 6.900% | 1,066,245 (+44.42%) | Filing History |
| 2025-08-20 5:20 pm Sale | 2025-08-18 | 13D | KALVISTA PHARMACEUTICALS INC C KALV | Frazier Life Sciences Public Fund, L.P. | 2,400,276 4.800% | -2,487,591 (-50.89%) | Filing History |
| 2025-05-15 4:15 pm Purchase | 2025-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL MANAGEMENT, LLC | 4,941,798 9.900% | 620,251 (+14.35%) | Filing History |
| 2025-05-13 11:44 am Sale | 2025-03-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Capital World Investors | 3,177,587 6.400% | -196,477 (-5.82%) | Filing History |
| 2025-02-03 7:43 pm Sale | 2025-01-30 | 13G | APPLIED THERAPEUTICS INC APLT | Venrock Healthcare Capital Partners III, L.P. | 5,012,796 10.100% | -6,643,269 (-56.99%) | Filing History |
| 2024-11-14 4:00 pm Purchase | 2024-09-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | TANG CAPITAL MANAGEMENT, LLC | 4,321,547 9.990% | 4,321,547 (New Position) | Filing History |
| 2024-11-14 3:57 pm Purchase | 2024-09-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Suvretta Capital Management, LLC | 4,328,904 9.990% | 1,644,899 (+61.29%) | Filing History |
| 2024-11-14 12:02 pm Purchase | 2024-09-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Vestal Point Capital, LP | 4,000,000 9.300% | 4,000,000 (New Position) | Filing History |
| 2024-11-13 12:54 pm Purchase | 2024-11-07 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Capital World Investors | 3,374,064 7.800% | 3,374,064 (New Position) | Filing History |
| 2024-11-12 4:05 pm Unchanged | 2024-09-30 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | VANGUARD GROUP INC | 2,150,527 4.970% | 0 (Unchanged) | Filing History |